- Home
- FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), High Glucose w/o L-Glutamine, Sodium Bicarbonate: 1X Liquid
FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), High Glucose w/o L-Glutamine, Sodium Bicarbonate: 1X Liquid
FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), High Glucose w/o L-Glutamine, Sodium Bicarbonate: 1X Liquid
FluxMPS™ DCP-DMEM-QB1X is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) DMEM High Glucose (4.5 g/L) formulation engineered for organ-on-a-chip (OoC), microphysiological systems (MPS), and other microfluidic cell culture platforms. Formulated without L-glutamine and without sodium bicarbonate for CO2-independent, fresh-nitrogen-definition culture, it reaches a 0.04 µm final filtration cut-off — a meaningful reduction in particulate load versus conventional 0.22 µm–filtered media.
- High Glucose (4.5 g/L) — supports energy-demanding cell types: primary neurons, cardiomyocytes, cancer lines
- Formulated without L-Glutamine and without Sodium Bicarbonate for CO2-independent, fresh-nitrogen-defined culture
- Quadruple-stage filtration train: 0.1 µm → 0.04 µm → 0.1 µm → 0.04 µm, reaching a 0.04 µm final cut-off
- Endotoxin release specification < 0.05 EU/mL (LAL, USP <85>), controlled per manufacturing batch
- Contains sodium pyruvate (110 mg/L) as a supplemental carbon/energy source
- Manufactured under an ISO 13485:2016 quality management system; final QC at Diagnocine, Totowa, NJ
- 31 verified ingredients per lot, including phenol red sodium salt (15.9 mg/L) for visual pH monitoring
- Custom pH, glucose concentration, salts, and nutrient adjustments available on request
- Glucose4500 mg/L (4.5 g/L, High Glucose)
- Formulation[+] Phenol Red, [+] Calcium, [+] Magnesium, [+] Glucose, [+] Sodium Pyruvate | [-] L-Glutamine, [-] Sodium Bicarbonate
- AppearanceOrange-colored, clear solution
- pH (USP <791>)7.4
- Osmolality (USP <785>)250–290 mOsm/kg H2O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2 (Quadruple-stage)
- Storage2–8°C, protect from light
- Shelf Life12 months from date of manufacture, unopened
- ShippingCold pack
Engineered where standard media fails
Conventional 0.22 µm–filtered DMEM allows mycoplasma-sized particles, subvisible particulates, and aggregates through that can accumulate in microfluidic channels and interfere with sensor readouts. FluxMPS™ High Glucose is filtered to a 0.04 µm final cut-off while delivering 4.5 g/L glucose for energy-demanding cell types and complex tissue models.
Microchannel-safe purity
0.04 µm final filtration; USP <788> Method 1 (light obscuration) particulate compliance supports reliable perfusion in narrow chip geometries, including sub-100 µm channels.
High-energy cell support
4.5 g/L glucose sustains primary neurons, cardiomyocytes, cancer lines, and other aerobically active cells in prolonged perfusion.
Ultrapure-grade water
Ultrapure Type 1 water (18.2 MΩ·cm) minimizes trace-metal and organic-carbon (TOC) background contamination during formulation.
Low background for imaging
Ultra-low particulate baseline (0.04 µm final filtration) supports confocal microscopy and biosensor platforms. Note: this formulation contains phenol red sodium salt (15.9 mg/L), which may contribute background fluorescence in some assay windows — phenol red–free variants are available on request.
Rich, stable nutrient profile
31 ingredients verified per lot; 4× BME amino acid/vitamin concentration; micro-batch production with full traceability.
Customization on demand
pH, glucose, salts, HEPES, and nutrients adjustable. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages — two dedicated 0.1 µm prefilter/0.04 µm final-filter pairs — reduce particulate load substantially below conventional single-pass 0.22 µm filtration.
-
1
0.1 µm Prefiltration I
Removes large aggregates, cell debris, and protein aggregates; protects the first 0.04 µm cartridge from early fouling.
-
2
0.04 µm Final filtration I
First 0.04 µm mycoplasma-retentive pass; retains sub-micron particulates and microaggregates that pass a 0.22 µm filter.
-
3
0.1 µm Prefiltration II
Second dedicated prefilter protecting the second 0.04 µm cartridge; not a polishing pass on the first filtrate.
-
4
0.04 µm Final filtration II — Polish
Second 0.04 µm pass and aseptic fill & finish under ISO Class 5 (Class 100) conditions.
Performance vs. conventional media
A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration.
© Diagnocine® — DCP-DMEM-QB1X
Designed for next-generation cell models
FluxMPS™ DCP-DMEM-QB1X supports demanding platforms from single-channel microfluidic chips to multi-organ body-on-a-chip systems. High glucose (4.5 g/L) makes it particularly suited to energy-intensive cell types and aerobically active cultures.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra-filtered MPS Grade variant of this formulation is available on request for automated bioreactor perfusion and robotic liquid handlers.
- Total Particulate Exclusion: 0.01 µm filtration removes nanoparticulate aggregates
- Valve & Sensor Protection: Reduces micro-fouling risk on solenoid valves and optical sensors
- Extended Perfusion Stability: Consistent high-glucose delivery over weeks-long culture
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.
Microphysiological Systems & Chip
0.04 µm–filtered media reduces microchannel clogging risk in complex multi-organ chip architectures.
Warburg Effect & Cancer Models
High glucose (4.5 g/L) supports aerobic glycolysis phenotyping in cancer cell lines requiring elevated energy substrates.
Primary Neurons & Brain-on-Chip
High glucose supports the metabolic demands of primary neurons and iPSC-derived neuronal networks in microfluidic perfusion.
Cardiomyocyte & Heart-on-Chip
High-glucose DMEM is widely used for iPSC-derived cardiomyocyte maturation and heart-on-chip functional assays.
Metabolic Flux Analysis
Defined high-glucose formulation for ¹³C isotope tracing and NMR-based metabolomics profiling of glycolytic flux. Not compatible with Agilent Seahorse XF assays, which require bicarbonate-free, phenol red-free medium — this formulation contains phenol red.
Microscopy & Optical Sensing
Ultra-low particulate baseline supports confocal and biosensor platforms; phenol red presence should be considered for fluorescence-sensitive assays.
Analytical release specifications
Every lot released against the full specification matrix. Available pack sizes: 500 mL, 1000 mL. CoA available on request: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] Phenol Red, [+] Calcium, [+] Magnesium, [+] Glucose (4500 mg/L), [+] Sodium Pyruvate (110 mg/L) | [-] L-Glutamine, [-] Sodium Bicarbonate |
| Appearance | Orange-colored, clear solution |
| Glucose | 4500 mg/L (4.5 g/L, High Glucose) |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 250–290 mOsm/kg H2O |
| Phenol Red | 15.9 mg/L (present) |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Ultrapure Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, protect from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | Bicarbonate-free; CO2-independent when buffered with HEPES (10–25 mM, add at use) or maintained in an open, atmospheric system |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
DMEM High Glucose is a modification of Basal Medium Eagle (BME) with 4× BME amino acid and vitamin concentrations, plus glycine, serine, and ferric nitrate. 31 ingredients verified per lot with CAS numbers for full raw-material traceability.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Ferric nitrate nonahydrate | 7782-61-8 | 0.100 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium chloride | 7647-14-5 | 6400.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 109.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 30.000 |
| L-Arginine hydrochloride | 1119-34-2 | 84.000 |
| L-Cystine dihydrochloride | 30925-07-6 | 62.570 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 42.000 |
| L-Isoleucine | 73-32-5 | 105.000 |
| L-Leucine | 61-90-5 | 105.000 |
| L-Lysine hydrochloride | 657-27-2 | 146.000 |
| L-Methionine | 63-68-3 | 30.000 |
| L-Phenylalanine | 63-91-2 | 66.000 |
| L-Serine | 56-45-1 | 42.000 |
| L-Threonine | 72-19-5 | 95.000 |
| L-Tryptophan | 73-22-3 | 16.000 |
| L-Tyrosine Disodium Salt dihydrate | 69847-15-0 | 103.790 |
| L-Valine | 72-18-4 | 94.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 4.000 |
| D-Ca-Pantothenate | 137-08-6 | 4.000 |
| Folic acid | 59-30-3 | 4.000 |
| Nicotinamide | 98-92-0 | 4.000 |
| Pyridoxal hydrochloride | 65-22-5 | 4.000 |
| Riboflavin | 83-88-5 | 0.400 |
| Thiamine hydrochloride | 67-03-8 | 4.000 |
| i-Inositol | 87-89-8 | 7.200 |
| OTHERS | ||
| D-Glucose | 50-99-7 | 4500.000 |
| Phenol red sodium salt | 34487-61-1 | 15.900 |
| Sodium pyruvate | 113-24-6 | 110.000 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system spanning raw materials, in-process controls, and final-product testing.
ISO 13485:2016 Quality Management
Manufactured under an ISO 13485:2016-certified quality management system. Final QC and release testing at the Diagnocine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm resistivity feed water, controlled for trace-metal and organic-carbon (TOC) background.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations, supporting container-closure integrity.
Micro-Batch Precision
Small-batch production with full per-lot traceability; a Certificate of Analysis is available for every batch.
Endotoxin — USP <85> BET
LAL assay; release specification < 0.05 EU/mL per manufacturing batch.
Particulate — USP <788> Method 1
Light obscuration particle count test: NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).
Osmolality — USP <785>
Freezing-point osmometry. Specification: 250–290 mOsm/kg H2O.
Documentation & CoA
Full CoA with raw-material traceability available for every batch on request.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-DMEM-QB1X compares
FluxMPS™ DCP-DMEM-QB1X vs. conventional 0.22 µm–filtered DMEM High Glucose formulations.
| Parameter | DCP-DMEM-QB1X (FluxMPS™) | Conventional DMEM HG (0.22 µm filtered) |
Standard Alt. DMEM HG (0.22 µm filtered) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Not specified | Not specified |
| Formulated without L-Glutamine and Sodium Bicarbonate (CO2-independent option) | check_circle Yes | cancel No | cancel No |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (Quadruple-stage) | 1 | 1 |
| Mycoplasma-retentive filtration | check_circle Yes (0.1 µm barrier) | cancel No | cancel No |
| Endotoxin (release specification) | < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> Method 1 particulate tested | check_circle Yes | cancel No | cancel No |
| Water quality | Type 1, 18.2 MΩ·cm | Purified water | Purified water |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or none | ISO 9001 or none |
| Microfluidic channel compatibility | check_circle Microfluidics Suitable (0.04 µm) | cancel Risk of clogging | cancel Risk of clogging |
| Custom formulation | check_circle Available | cancel Fixed | cancel Fixed |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-DMEM-QB1X DMEM High Glucose.
Supporting literature
Key peer-reviewed publications supporting Microfluidics Suitable, ultra-filtered DMEM High Glucose in organ-on-a-chip and metabolic research.
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Warburg O. On the origin of cancer cells. Science. 1956;123:309–314. doi:10.1126/science.123.3191.309
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Katt ME, et al. In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform. Front Bioeng Biotechnol. 2016;4:12. doi:10.3389/fbioe.2016.00012
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Sung JH, et al. Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j
- Zhang B, Radisic M. Organ-on-a-chip devices advance to market. Lab Chip. 2017;17:2395–2420. doi:10.1039/c6lc01554a
